← Browse by Condition
Medical Condition
braf v600 mutation
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2
NCT05800340 Phase 2
Recruiting
Neoadjuvant Immunotherapy in Rare Mutations Localized NSCLC
Enrollment
30 pts
Location
China
Sponsor
Guangdong Provincial People's ...
NCT06749015
Recruiting
A Study on Treatment for Patients With BRAFV600E Mutant Metastatic Colorectal Cancer (mCRC)
Enrollment
100 pts
Location
China
Sponsor
Fudan University